About the Authors

Florian Clatot

Roles Validation, Writing – review & editing

Affiliation Centre Henri-Becquerel, Rouen, France

Caroline Even

Roles Validation, Writing – review & editing

Affiliation Gustave Roussy, Villejuif, France

Amaury Daste

Roles Validation, Writing – review & editing

Affiliation CHU de Bordeaux, Bordeaux, France

Christian Borel

Roles Conceptualization, Validation, Writing – review & editing

Affiliation ICANS Strasbourg, Strasbourg, France

Jérôme Fayette

Roles Conceptualization, Validation, Writing – review & editing

Affiliation Centre Léon Bérard, Lyon, France

Myriam Chebbah

Roles Conceptualization, Formal analysis, Resources, Writing – original draft, Writing – review & editing

Affiliation Public Health Expertise, Paris, France

Solenn Le Clanche

Roles Conceptualization, Formal analysis, Resources, Writing – original draft, Writing – review & editing

Affiliation Public Health Expertise, Paris, France

Esma Saada

Roles Validation, Writing – review & editing

Esma.SAADA@nice.unicancer.fr

Affiliations Medical Oncology Department, Centre Antoine Lacassagne, Nice, France, Laboratory of Translational Research in Oncology, Université Côte d’Azur, Nice, France

Competing Interests

Florian CLATOT has received payments or honoraria for lectures, presentations, speaker bureau activities, manuscript writing, or educational events, as well as support for attending meetings and/or travel from Merck and MSD. Caroline EVEN has received support for attending meetings and/or travel from Merck Serrono and MSD. Amaury DASTE has received consulting fees from Merck, MSD, BMS, Merus and has received support for attending meetings and/or travel from Merck and MSD. Christian BOREL has received consulting fees from PHE, MSD, Merck KGaA, has received payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from MSD and Merck KGaA and received support for attending meetings and/or travel from MSD and Merck KGaA. Jérôme FAYETTE has received consulting fees from AstraZeneca, Hookipa, Innate pharma, Merck Serrono, MSD, Pfizer, Roche. Esma SAADA received grants from Merck Serrono and Astrazeneca, consulting fees from MSD, BMS, Lilly, Merck Serrono, payments or honoraria for lectures, presentations, speaker bureau activities, manuscript writing, or educational events from Merck Serrono and has received support for attending meetings and/or travel from Merck Serrono, MSD and Novartis. Myriam CHEBBAH and Solenn LE CLANCHE have no conflicts of interests to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.